SCHEMBL21101768

SCHEMBL21101768

COc1cc(CC(C)=O)cc(C(C)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.44
RXRB P28702 1/20 0.44
RXRG P48443 1/20 0.44
CYP3A4 P08684 2/20 0.37
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HTT P42858 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
POLB P06746 2/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAOA P21397 1/20 0.35
SLC6A2 P23975 1/20 0.35
RAB9A P51151 1/20 0.35
SLC6A3 Q01959 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29168790 0.81 CYP3A4 (0.47) CYP3A4KDM4EMEN1KMT2AALDH1A1
SCHEMBL1162659 0.81 ALDH1A1 (0.48) CYP3A4KDM4EMEN1KMT2AALDH1A1
SCHEMBL21101912 0.80 TACR1 (0.35) RXRARXRBRXRGPOLBCYP1A2
SCHEMBL4670746 0.76 RXRA (0.70) RXRARXRBRXRGKDM4EMEN1
SCHEMBL17089023 0.75 ALDH1A1 (0.55) RXRARXRBRXRGCYP3A4ALDH1A1
SCHEMBL15478104 0.75 CYP3A4 (0.42) CYP3A4KDM4EPOLBMAPTNPC1
SCHEMBL21101918 0.74 TACR1 (0.37) RXRARXRBRXRGCYP3A4POLB
SCHEMBL7794784 0.74 RXRA (0.52) RXRARXRBRXRGKDM4EALDH1A1
SCHEMBL21102124 0.74 RXRA (0.38) RXRARXRBRXRGKDM4EMEN1
SCHEMBL21102126 0.73 MARS1 (0.43) CYP3A4KDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed